Texas § 1369.223 COVERAGE REQUIREMENTS.

Texas Statutes

§ 1369.223 — COVERAGE REQUIREMENTS.

Texas § 1369.223

Code INInsurance Code

This text of Texas § 1369.223 (COVERAGE REQUIREMENTS.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Insurance Code Code Ann. § 1369.223 (2026).

Text

Sec. 1369.223. COVERAGE REQUIREMENTS. A health benefit plan that provides coverage for chimeric antigen receptor T-cell therapy must provide coverage for chimeric antigen receptor T-cell therapy that is:

(1)medically necessary; and

(2)administered by a health care provider that is:

(A)qualified as a certified health care facility in accordance with the procedure for the chimeric antigen receptor T-cell therapy product license approved by the United States Food and Drug Administration; and

(B)participating in the health benefit plan's network with respect to any other service.

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 1369.223. COVERAGE REQUIREMENTS. A health benefit plan that provides coverage for chimeric antigen receptor T-cell therapy must provide coverage for chimeric antigen receptor T-cell therapy that is:
(1) medically necessary; and
(2) administered by a health care provider that is:
(A) qualified as a certified health care facility in accordance with the procedure for the chimeric antigen receptor T-cell therapy product license approved by the United States Food and Drug Administration; and
(B) participating in the health benefit plan's network with respect to any other service.